These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 17012902

  • 1. Preclinical laboratory evaluation of a bivalent Staphylococcus aureus saccharide-exotoxin A protein conjugate vaccine.
    Ho MM, Bolgiano B, Martino A, Kairo SK, Corbel MJ.
    Hum Vaccin; 2006; 2(3):89-98. PubMed ID: 17012902
    [Abstract] [Full Text] [Related]

  • 2. Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A.
    Fattom A, Schneerson R, Watson DC, Karakawa WW, Fitzgerald D, Pastan I, Li X, Shiloach J, Bryla DA, Robbins JB.
    Infect Immun; 1993 Mar; 61(3):1023-32. PubMed ID: 8432585
    [Abstract] [Full Text] [Related]

  • 3. First characterization of immunogenic conjugates of Vi negative Salmonella Typhi O-specific polysaccharides with rEPA protein for vaccine development.
    Salman M, St Michael F, Ali A, Jabbar A, Cairns C, Hayes AC, Rahman M, Iqbal M, Haque A, Cox AD.
    J Immunol Methods; 2017 Nov; 450():27-33. PubMed ID: 28735760
    [Abstract] [Full Text] [Related]

  • 4. Effect of conjugation methodology, carrier protein, and adjuvants on the immune response to Staphylococcus aureus capsular polysaccharides.
    Fattom A, Li X, Cho YH, Burns A, Hawwari A, Shepherd SE, Coughlin R, Winston S, Naso R.
    Vaccine; 1995 Oct; 13(14):1288-93. PubMed ID: 8585282
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A.
    Fattom A, Schneerson R, Szu SC, Vann WF, Shiloach J, Karakawa WW, Robbins JB.
    Infect Immun; 1990 Jul; 58(7):2367-74. PubMed ID: 2114365
    [Abstract] [Full Text] [Related]

  • 6. Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam.
    Kossaczka Z, Lin FY, Ho VA, Thuy NT, Van Bay P, Thanh TC, Khiem HB, Trach DD, Karpas A, Hunt S, Bryla DA, Schneerson R, Robbins JB, Szu SC.
    Infect Immun; 1999 Nov; 67(11):5806-10. PubMed ID: 10531232
    [Abstract] [Full Text] [Related]

  • 7. Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study.
    Fattom A, Matalon A, Buerkert J, Taylor K, Damaso S, Boutriau D.
    Hum Vaccin Immunother; 2015 Nov; 11(3):632-41. PubMed ID: 25483694
    [Abstract] [Full Text] [Related]

  • 8. Safety and immunogenicity of Staphylococcus aureus type 5 capsular polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugate vaccine in patients on hemodialysis.
    Welch PG, Fattom A, Moore J, Schneerson R, Shiloach J, Bryla DA, Li X, Robbins JB.
    J Am Soc Nephrol; 1996 Feb; 7(2):247-53. PubMed ID: 8785394
    [Abstract] [Full Text] [Related]

  • 9. Preparation and immunogenicity-evaluation of typhoid O-specific polysaccharides bio-conjugate vaccines.
    Peng ZH, Pan C, Sun P, Feng EL, Wu J, Zhu L, Peng QZ, Wang HL.
    Yi Chuan; 2015 May; 37(5):473-9. PubMed ID: 25998436
    [Abstract] [Full Text] [Related]

  • 10. Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX) in hemodialysis patients.
    Fattom A, Fuller S, Propst M, Winston S, Muenz L, He D, Naso R, Horwith G.
    Vaccine; 2004 Dec 16; 23(5):656-63. PubMed ID: 15542186
    [Abstract] [Full Text] [Related]

  • 11. Effect of dosage on immunogenicity of a Vi conjugate vaccine injected twice into 2- to 5-year-old Vietnamese children.
    Canh DG, Lin FY, Thiem VD, Trach DD, Trong ND, Mao ND, Hunt S, Schneerson R, Robbins JB, Chu C, Shiloach J, Bryla DA, Bonnet MC, Schulz D, Szu SC.
    Infect Immun; 2004 Nov 16; 72(11):6586-8. PubMed ID: 15501790
    [Abstract] [Full Text] [Related]

  • 12. Is Pseudomonas aeruginosa exotoxin A a good carrier protein for conjugate vaccines?
    Pier GB.
    Hum Vaccin; 2007 Nov 16; 3(2):39-40; author reply 41. PubMed ID: 17268204
    [No Abstract] [Full Text] [Related]

  • 13. Conjugating recombinant proteins to Pseudomonas aeruginosa ExoProtein A: a strategy for enhancing immunogenicity of malaria vaccine candidates.
    Qian F, Wu Y, Muratova O, Zhou H, Dobrescu G, Duggan P, Lynn L, Song G, Zhang Y, Reiter K, MacDonald N, Narum DL, Long CA, Miller LH, Saul A, Mullen GE.
    Vaccine; 2007 May 16; 25(20):3923-33. PubMed ID: 17428587
    [Abstract] [Full Text] [Related]

  • 14. Immunogenicity and safety of a tetravalent E. coli O-antigen bioconjugate vaccine in animal models.
    van den Dobbelsteen GPJM, Faé KC, Serroyen J, van den Nieuwenhof IM, Braun M, Haeuptle MA, Sirena D, Schneider J, Alaimo C, Lipowsky G, Gambillara-Fonck V, Wacker M, Poolman JT.
    Vaccine; 2016 Jul 29; 34(35):4152-4160. PubMed ID: 27395567
    [Abstract] [Full Text] [Related]

  • 15. Comparative immunogenicity of conjugates composed of the Staphylococcus aureus type 8 capsular polysaccharide bound to carrier proteins by adipic acid dihydrazide or N-succinimidyl-3-(2-pyridyldithio)propionate.
    Fattom A, Shiloach J, Bryla D, Fitzgerald D, Pastan I, Karakawa WW, Robbins JB, Schneerson R.
    Infect Immun; 1992 Feb 29; 60(2):584-9. PubMed ID: 1730492
    [Abstract] [Full Text] [Related]

  • 16. The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children.
    Lin FY, Ho VA, Khiem HB, Trach DD, Bay PV, Thanh TC, Kossaczka Z, Bryla DA, Shiloach J, Robbins JB, Schneerson R, Szu SC.
    N Engl J Med; 2001 Apr 26; 344(17):1263-9. PubMed ID: 11320385
    [Abstract] [Full Text] [Related]

  • 17. Epitopic overload at the site of injection may result in suppression of the immune response to combined capsular polysaccharide conjugate vaccines.
    Fattom A, Cho YH, Chu C, Fuller S, Fries L, Naso R.
    Vaccine; 1999 Jan 26; 17(2):126-33. PubMed ID: 9987146
    [Abstract] [Full Text] [Related]

  • 18. Immunogenicity of synthetic saccharide fragments of Vibrio cholerae O1 (Ogawa and Inaba) bound to Exotoxin A.
    Wade TK, Saksena R, Shiloach J, Kovác P, Wade WF.
    FEMS Immunol Med Microbiol; 2006 Nov 26; 48(2):237-51. PubMed ID: 17010106
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.